Skip to content
10-Q

Quarterly Report

Nuo Therapeutics, Inc. AURX

0001437749-24-017125

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 13, 2024 44.24M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $366.23K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $928.68K
Cash And Equivalents Q1 2024 · Mar 31, 2023 $1.25M
Cash And Equivalents Q1 2024 · Dec 31, 2022 $2.05M
Current Liabilities Q1 2024 · Mar 31, 2024 $761.28K
Current Liabilities Q1 2024 · Dec 31, 2023 $674.53K
Total Liabilities Q1 2024 · Mar 31, 2024 $909.39K
Total Liabilities Q1 2024 · Dec 31, 2023 $838.73K
Current Assets Q1 2024 · Mar 31, 2024 $981.09K
Current Assets Q1 2024 · Dec 31, 2023 $1.56M
Total Assets Q1 2024 · Mar 31, 2024 $1.24M
Total Assets Q1 2024 · Dec 31, 2023 $1.88M
Capex Q1 2024 · Mar 31, 2023 $5.34K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$795.6K
Stockholders Equity Q1 2024 · Mar 31, 2023 $1.34M
Stockholders Equity Q1 2024 · Dec 31, 2022 $2.19M
Eps Basic Q1 2024 · Mar 31, 2023 −$0.02
Sga Expense Q1 2024 · Mar 31, 2023 $905.87K
Net Income Q1 2024 · Mar 31, 2023 −$855.76K
Operating Income Q1 2024 · Mar 31, 2023 −$855.19K
Gross Profit Q1 2024 · Mar 31, 2023 $50.68K